Browsing by Author Bosomprah, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
2011Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the kasena-nankana district of northern ghana.Dodoo, D.; Atuguba, F.; Bosomprah, S.; Ansah, N.A.; Ansah, P.; Lamptey, H.; Egyir, B.; Oduro, A.R.; Gyan, B.; Hodgson, A.; Koram, K.A.
2008Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian childrenDodoo, D.; Kusi, K.A.; Aikins, A.; Lamptey, H.; Remarque, E.; Milligan, P.; Bosomprah, S.; Chilengi, R.; Osei, Y.D.; Akanmori, B.D.; Theisen, M.
10-Dec-2007Humoral responses to plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.Nebie, I.; Diarra, A.; Ouedraogo, A.; Bosomprah, S.; Bougouma, E.C.; Tiono, A.B.; Konate, A.T.; Chilengi, R.; Theisen, M.; Dodoo, D.; Remarque, E.; Milligan, P.; Sirima, S.B.
2-Feb-2012Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population.Kusi, K.A.; Dodoo, D.; Bosomprah, S.; van de Eijk, M.; Faber, B.W.; Kocken, C.H.M.; Remarque, E.J.
17-Jul-2009Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in tanzanian children aged 12-24 months.Lusingu, J.P.; Gesase, S.; Bosomprah, S.; Francis, F.; Lemnge, M.; Seth, M.; Sebuche, S.; Rutta, A.; Minja, D.; Segeja, M.D.; Cousens, S.; Noor, R.; Chilengi, R.; Druilhe, P.